As expected, FTX was purified and characterized with an Mw of 26.78 kDa (Figure 2 and Figure 3), which significantly restrained cancer cell growth, especially for HepG2, with a time- and dose-dependent relationship (Figure 4D–F). This evidence concerns the gene FTX and cancer.